212 related articles for article (PubMed ID: 1932223)
21. Hematopoietic growth factors in autologous bone marrow transplantation.
Miller AM
Semin Oncol; 1993 Oct; 20(5 Suppl 6):88-95. PubMed ID: 7692607
[TBL] [Abstract][Full Text] [Related]
22. Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey.
Repetto L;
Crit Rev Oncol Hematol; 2009 Nov; 72(2):170-9. PubMed ID: 19406660
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
Grossi F; Tiseo M
Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
[TBL] [Abstract][Full Text] [Related]
24. Epoetin alfa and high-dose chemotherapy.
Henry DH
Semin Oncol; 1998 Jun; 25(3 Suppl 7):54-7. PubMed ID: 9671332
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of neutropenia in HIV infection with hematopoietic growth factors].
Moreno García M; Fernández González F
Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065
[No Abstract] [Full Text] [Related]
26. A review of the efficacy and tolerability of recombinant haematopoietic growth factors in bone marrow transplantation.
Barge AJ
Bone Marrow Transplant; 1993; 11 Suppl 2():1-11. PubMed ID: 8334433
[TBL] [Abstract][Full Text] [Related]
27. The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.
Crawford J; George M
Semin Oncol; 1995 Jun; 22(3 Suppl 7):18-22. PubMed ID: 7541916
[TBL] [Abstract][Full Text] [Related]
28. Hematopoietic growth factors in the treatment of acquired bone marrow failure states.
Marsh JC; Ganser A; Stadler M
Semin Hematol; 2007 Jul; 44(3):138-47. PubMed ID: 17631178
[TBL] [Abstract][Full Text] [Related]
29. Future directions with hematopoietic growth factors.
Vadhan-Raj S
J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S96-101. PubMed ID: 19795582
[TBL] [Abstract][Full Text] [Related]
30. A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy.
Sosman JA; Stiff PJ; Bayer RA; Peliska J; Peace DJ; Loutfi S; Stock W; Oldenburg D; Unverzagt K; Bender J
Bone Marrow Transplant; 1995 Nov; 16(5):655-61. PubMed ID: 8547862
[TBL] [Abstract][Full Text] [Related]
31. [The use of erythropoietin alpha in programs of high-dose chemotherapy].
Danova M; Aglietta M; Pierelli L; Ferrari S; Perillo A; Scambia G; Henry D
Recenti Prog Med; 2000 Dec; 91(12):681-9. PubMed ID: 11194490
[TBL] [Abstract][Full Text] [Related]
32. Clinical applications of hematopoietic growth factors.
Vose JM; Armitage JO
J Clin Oncol; 1995 Apr; 13(4):1023-35. PubMed ID: 7535842
[TBL] [Abstract][Full Text] [Related]
33. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
Henry DH; Abels RI
Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
[TBL] [Abstract][Full Text] [Related]
35. Hematopoietic growth factors in myelodysplastic syndromes.
Blinder VS; Roboz GJ
Curr Hematol Rep; 2003 Nov; 2(6):453-8. PubMed ID: 14561388
[TBL] [Abstract][Full Text] [Related]
36. The clinical use of hematopoietic growth factors.
Appelbaum FR
Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905
[TBL] [Abstract][Full Text] [Related]
37. [Clinical use of hematopoietic growth factors].
Krusius T
Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
[No Abstract] [Full Text] [Related]
38. Prevention of chemotherapy-induced anemia and thrombocytopenia by constant administration of stem cell factor.
Bartucci M; Dattilo R; Martinetti D; Todaro M; Zapparelli G; Di Virgilio A; Biffoni M; De Maria R; Zeuner A
Clin Cancer Res; 2011 Oct; 17(19):6185-91. PubMed ID: 21868766
[TBL] [Abstract][Full Text] [Related]
39. [Bone marrow suppression].
Urabe A
Nihon Rinsho; 2003 Jun; 61(6):949-53. PubMed ID: 12806941
[TBL] [Abstract][Full Text] [Related]
40. [Myelosuppression due to antineoplastic agents].
Shigeoka Y; Shimizu E
Nihon Rinsho; 2007 Oct; 65 Suppl 8():287-93. PubMed ID: 18074550
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]